Keely Beck Zipp is an experienced executive in the biotechnology and pharmaceutical industries, currently serving as the Vice President of Immunoglobulins TA & Global Commercial Development Portfolio Planning at CSL since December 2024. Prior roles include Vice President of Commercial Strategy and Innovation at Pfizer, where leadership was provided for asset and portfolio strategies in internal medicine and hematology, and as Strategic Advisor at Stark Strategic Advisors LLC, offering business development and commercialization strategies. Zipp has also held key positions at Lava Therapeutics B.V. and Cybrexa Therapeutics, successfully expanding product pipelines and supporting significant IPOs. Previous experience includes roles at Incyte and GSK, focusing on strategic planning, operational excellence, and global marketing in oncology. Zipp holds an M.B.A. in Finance and Health Care Management from The Wharton School and a BA in Biochemistry from Dartmouth College.
This person is not in any teams
This person is not in any offices